News + Filings Transactions
|
GORDON CARL L
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 08/14/2023 | Adicet Bio, Inc. | TORC | Grant | Stock Option (Right to Buy) | 30k | $0.00 | $0 | | 08/14/2023 |
| 08/14/2023 | Adicet Bio, Inc. | TORC | Disposition | Stock Option (Right to Buy) | 18.5k | $15.93 | $294.7k | | 08/14/2023 |
| 08/14/2023 | Adicet Bio, Inc. | TORC | Grant | Stock Option (Right to Buy) | 18.5k | $0.00 | $0 | | 08/14/2023 |
| 08/14/2023 | Adicet Bio, Inc. | TORC | Disposition | Stock Option (Right to Buy) | 18.5k | $11.49 | $212.6k | | 08/14/2023 |
| 08/14/2023 | Adicet Bio, Inc. | TORC | Disposition | Stock Option (Right to Buy) | 26.4k | $5.20 | $137.1k | | 08/14/2023 |
| 08/14/2023 | Adicet Bio, Inc. | TORC | Grant | Stock Option (Right to Buy) | 26.4k | $0.00 | $0 | | 08/14/2023 |
| 08/14/2023 | Adicet Bio, Inc. | TORC | Disposition | Stock Option (Right to Buy) | 30k | $16.11 | $483.3k | | 08/14/2023 |
| 07/17/2023 | Theseus Pharmaceuticals, Inc. | THRX | Purchase | Common Stock | 328.5k | $3.05 | $1M | See Footnotes | 07/17/2023 |
| 07/17/2023 | Theseus Pharmaceuticals, Inc. | THRX | Purchase | Common Stock | 151.4k | $3.05 | $461.9k | See Footnotes | 07/17/2023 |
| 06/27/2023 | Adicet Bio, Inc. | TORC | Purchase | Common Stock | 58k | $2.09 | $121.2k | See footnotes | 06/27/2023 |
| 06/27/2023 | Adicet Bio, Inc. | TORC | Purchase | Common Stock | 442k | $2.09 | $923.8k | See footnotes | 06/27/2023 |
| 06/27/2023 | Adicet Bio, Inc. | TORC | Purchase | Common Stock | 250k | $2.09 | $522.5k | See footnotes | 06/27/2023 |
| 06/27/2023 | Adicet Bio, Inc. | TORC | Purchase | Common Stock | 125k | $2.09 | $261.2k | See footnotes | 06/27/2023 |
| 06/06/2023 | Keros Therapeutics, Inc. | KROS | Grant | Stock Option (right to buy) | 10k | $48.79 | $487.9k | | 06/06/2023 |
| 06/01/2023 | Adicet Bio, Inc. | TORC | Grant | Common Stock | 5.9k | $0.00 | $0 | | 06/01/2023 |
| 06/01/2023 | Adicet Bio, Inc. | TORC | Grant | Stock Option (Right to Buy) | 26.4k | $5.20 | $137.1k | | 06/01/2023 |
| 05/05/2023 | Kinnate Biopharma Inc. | | Purchase | Common Stock | 490.5k | $2.82 | $1.4M | See footnotes | 05/04/2023 |
| 05/05/2023 | Kinnate Biopharma Inc. | | Purchase | Common Stock | 490.5k | $2.82 | $1.4M | See footnotes | 05/04/2023 |
| 05/04/2023 | Kinnate Biopharma Inc. | | Purchase | Common Stock | 83.5k | $2.75 | $229.5k | See footnotes | 05/04/2023 |
| 05/04/2023 | Kinnate Biopharma Inc. | | Purchase | Common Stock | 313k | $2.75 | $860.7k | See footnotes | 05/04/2023 |
| 05/04/2023 | Kinnate Biopharma Inc. | | Purchase | Common Stock | 83.5k | $2.75 | $229.5k | See footnotes | 05/04/2023 |
| 05/02/2023 | Kinnate Biopharma Inc. | | Purchase | Common Stock | 58.8k | $2.67 | $157.1k | See footnotes | 04/28/2023 |
| 05/02/2023 | Kinnate Biopharma Inc. | | Purchase | Common Stock | 220.6k | $2.67 | $589k | See footnotes | 04/28/2023 |
| 05/02/2023 | Kinnate Biopharma Inc. | | Purchase | Common Stock | 58.8k | $2.67 | $157.1k | See footnotes | 04/28/2023 |
| 05/01/2023 | Kinnate Biopharma Inc. | | Purchase | Common Stock | 124.5k | $2.62 | $326.3k | See footnotes | 04/28/2023 |
| 05/01/2023 | Kinnate Biopharma Inc. | | Purchase | Common Stock | 467.1k | $2.62 | $1.2M | See footnotes | 04/28/2023 |
| 05/01/2023 | Kinnate Biopharma Inc. | | Purchase | Common Stock | 124.5k | $2.62 | $326.3k | See footnotes | 04/28/2023 |
| 04/28/2023 | Kinnate Biopharma Inc. | | Purchase | Common Stock | 61k | $2.55 | $155.5k | See footnotes | 04/28/2023 |
| 04/28/2023 | Kinnate Biopharma Inc. | | Purchase | Common Stock | 228.8k | $2.55 | $583.3k | See footnotes | 04/28/2023 |
| 04/28/2023 | Kinnate Biopharma Inc. | | Purchase | Common Stock | 61k | $2.55 | $155.5k | See footnotes | 04/28/2023 |
| 02/17/2023 | Kinnate Biopharma Inc. | | Grant | Common Stock | 550k | $0.00 | $0 | See footnotes | 02/17/2023 |
| 02/17/2023 | Kinnate Biopharma Inc. | | Grant | Common Stock | 550k | $0.00 | $0 | See footnotes | 02/17/2023 |
| 02/08/2023 | Compass Therapeutics, Inc. | CMPX | Grant | Stock Option (Right to Buy) | 60k | $3.93 | $235.8k | | 02/08/2023 |
| 12/23/2022 | Terns Pharmaceuticals, Inc. | | Purchase | Common Stock | 137.9k | $7.25 | $1000k | See footnotes | 12/23/2022 |
| 11/08/2022 | Compass Therapeutics, Inc. | CMPX | Purchase | Common Stock | 402k | $3.21 | $1.3M | See Footnotes | 11/08/2022 |
|
|